Form 4: CalciMedica Director Allan Shaw Acquires Stock Options
SEC Form 4 Filing
Director Allan Shaw acquired stock options for 10,000 shares of CalciMedica, Inc. at an exercise price of $4.16 on August 27, 2024.
Summary
- On August 27, 2024, Allan Shaw, a director of CalciMedica, Inc., acquired stock options for 10,000 shares.
- The exercise price of these options is $4.16 per share.
- The options vest monthly over a one-year period starting March 28, 2024.
- The options expire on August 26, 2034.
- Following the transaction, Shaw directly owns options for 10,000 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option acquisition by a director.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Start date for monthly vesting of stock options. |
| August 27, 2024 | Date of transaction: Allan Shaw acquired stock options. |
| August 28, 2024 | Date of filing. |
| August 26, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.